AirSculpt Technologies (NASDAQ:AIRS) Raised to “Hold” at Wall Street Zen

AirSculpt Technologies (NASDAQ:AIRS) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Sunday.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, AirSculpt Technologies presently has an average rating of “Reduce” and a consensus target price of $6.00.

AirSculpt Technologies Price Performance

AIRS stock opened at $3.17 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.51 and a current ratio of 0.51. The stock has a 50-day simple moving average of $2.34 and a 200-day simple moving average of $4.35. The firm has a market cap of $223.64 million, a P/E ratio of -16.68 and a beta of 2.22. AirSculpt Technologies has a 1 year low of $1.51 and a 1 year high of $12.00.

AirSculpt Technologies (NASDAQ:AIRS) last posted its earnings results on Thursday, April 2nd. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.05. The firm had revenue of $33.44 million for the quarter, compared to analysts’ expectations of $34.93 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%.The firm’s revenue was down 14.8% compared to the same quarter last year. During the same period last year, the firm earned ($0.09) EPS. On average, equities analysts predict that AirSculpt Technologies will post -0.01 earnings per share for the current fiscal year.

Insider Activity

In related news, major shareholder Jorey Chernett purchased 105,848 shares of the company’s stock in a transaction on Monday, March 16th. The shares were bought at an average price of $2.43 per share, with a total value of $257,210.64. Following the completion of the acquisition, the insider owned 6,592,059 shares of the company’s stock, valued at approximately $16,018,703.37. This represents a 1.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders have purchased 600,150 shares of company stock valued at $1,404,424. Insiders own 76.58% of the company’s stock.

Institutional Investors Weigh In On AirSculpt Technologies

Several hedge funds have recently modified their holdings of AIRS. Virtu Financial LLC acquired a new position in shares of AirSculpt Technologies in the 4th quarter valued at $30,000. Millennium Management LLC acquired a new position in shares of AirSculpt Technologies in the fourth quarter worth about $33,000. Aigen Investment Management LP purchased a new position in shares of AirSculpt Technologies in the fourth quarter worth approximately $36,000. Wells Fargo & Company MN raised its holdings in shares of AirSculpt Technologies by 49.9% during the fourth quarter. Wells Fargo & Company MN now owns 19,275 shares of the company’s stock valued at $38,000 after acquiring an additional 6,420 shares during the period. Finally, BNP Paribas Financial Markets raised its holdings in shares of AirSculpt Technologies by 239.5% during the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after acquiring an additional 4,199 shares during the period. 91.54% of the stock is owned by hedge funds and other institutional investors.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.